Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$170K
Net Open-Market Flow
-$170K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Sell(S)31$165.70$5K12K
Apr 22, 2026Sell(S)20$166.32$3K12K
Apr 22, 2026Sell(S)141$167.42$24K11K
Apr 22, 2026Sell(S)101$168.64$17K11K
Apr 22, 2026Sell(S)105$169.52$18K11K
Apr 22, 2026Sell(S)75$170.58$13K11K
Apr 22, 2026Sell(S)257$171.62$44K11K
Apr 22, 2026Sell(S)249$172.49$43K11K
Apr 22, 2026Sell(S)21$173.04$4K11K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-173761) within minutes of acceptance. Every field above traces to the original document. Verify it directly: